Clinical Trial Research
Arena Pharmaceuticals Announces First Quarter 2007 Financial Results
Published in Drug Law Weekly, May 1st, 2007
Total revenues in the first quarter of 2007 were $4.9 million, compared to $12.1 million in the first quarter of 2006. Revenues in the first quarter of 2006 included a $5.0 million milestone under our collaboration with Ortho-McNeil Pharmaceutical, Inc. related to the initiation of a Phase 1 clinical trial of APD668 for the treatment of type 2 diabetes. Arena reported a net loss allocable to common stockholders in the first quarter of 2007 of $32.4 million, or $0.53 per share. This compares with a net loss allocable to common stockholders in the first quarter...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-05-01)
More Articles from Drug Law Weekly
- Cancer
Eisai Announces Completion of Acquisition of Morphotek - Clinical Trial Research
Cell Genesys Announces Registered Direct Common Stock and Warrant Offering of $60 Million - Drug Safety
Poll: Consumers Say Government Failed to Protect them from Dangerous Prescription Drugs; Americans Back Host of Drug Safety Reforms - Financing
CytRx Enters into Agreements for $37.0 Million Private Placement - Lerach Coughlin Stoia Geller Rudman & Robbins LLP
Lerach Coughlin Stoia Geller Rudman & Robbins LLP Files Class Action Suit against Amgen Inc. - Medicare and Medicaid
Cell Therapeutics, Inc. to Pay United States $10.5 Million to Resolve Claims for Illegal Marketing of Cancer Drug - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
